Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia/Lymphoma
University of Washington
University of Washington
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
University of Washington
Canadian Cancer Trials Group
City of Hope Medical Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
Thomas Jefferson University
Masonic Cancer Center, University of Minnesota
Seagen Inc.
St. Jude Children's Research Hospital
Center for International Blood and Marrow Transplant Research
University of Miami
Memorial Sloan Kettering Cancer Center
First Affiliated Hospital of Zhejiang University
University of Nebraska
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
National Institutes of Health Clinical Center (CC)
OHSU Knight Cancer Institute
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Fred Hutchinson Cancer Center
Virginia Commonwealth University
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Polish Lymphoma Research Group
The Lymphoma Academic Research Organisation
National Institutes of Health Clinical Center (CC)
GPCR Therapeutics, Inc.
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center